Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Karen L. Hoelzer"'
Autor:
Julie L. Ryan, Joseph A. Roscoe, Ann Dozier, Anita R. Peoples, Charlotte E. Coles, Michelle C. Janelsins, Charles E. Heckler, Karen L. Hoelzer, Karen M. Mustian, Luke J. Peppone, Gary R. Morrow, Dennis F. Moore, Robert C. Block
Publikováno v:
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer. 25(4)
Cancer-related fatigue (CRF) is a prevalent and distressing side effect of cancer and its treatment that remains inadequately understood and poorly managed. A better understanding of the factors contributing to CRF could result in more effective stra
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::67f3613d7ee62dd670dfa947c706d15e
https://pubmed.ncbi.nlm.nih.gov/27995318
https://pubmed.ncbi.nlm.nih.gov/27995318
Autor:
Andrew Jacobs, Joseph A. Roscoe, Gary R. Morrow, Charles E. Heckler, Bryan D. Pudlo, Lauren K. Colman, Karen L. Hoelzer, Ben Colagiuri
To identify risk factors for chemotherapy-related nausea. We examined risk factors for nausea in 1,696 patients from three multicenter studies conducted from 1998 to 2004. All patients were beginning a chemotherapy regimen containing cisplatin, carbo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4f64fcbb7e670148450b038c1ed593a8
https://europepmc.org/articles/PMC3017350/
https://europepmc.org/articles/PMC3017350/
Autor:
Christopher W. Bole, Tom R. Fitch, Jane T. Hickok, Karen L. Hoelzer, Gary R. Morrow, Hongwei Zhao, Joseph A. Roscoe, Shaker R. Dakhil, Timothy Moore
Summary Background Despite widespread use of short-acting antagonists for the 5-hydroxytryptamine (5-HT) receptor, about 50% of patients given moderately emetogenic chemotherapy have delayed nausea. We aimed to assess whether a 5-HT-receptor antagoni
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bca9dd3715f28e2ecb571b7c5c11fd40
https://europepmc.org/articles/PMC1646426/
https://europepmc.org/articles/PMC1646426/
Publikováno v:
Drug Intelligence & Clinical Pharmacy. 20:287-289
Two of 33 patients entered in a local pilot study of mitomycin, vinblastine, and cisplatin for non-small cell lung cancer developed vinblastine-associated pulmonary toxicity. As with other reports of vinca alkaloid-related pulmonary toxicity, the reg
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d46b40edcc0dde1c241f4cce395197cb
https://doi.org/10.1177/106002808602000415
https://doi.org/10.1177/106002808602000415